An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial

This publication has 16 references indexed in Scilit:

• Structured treatment interruptions in HIV/AIDS therapy
  Microbes and Infection, 2002
• Two-Year Outcome of a Multidrug Regimen in Patients Who Did Not Respond to a Protease Inhibitor Regimen
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Planned interruptions of anti-HIV treatment
  The Lancet Infectious Diseases, 2001
• Mutational Patterns in the HIV Genome and Cross-Resistance following Nucleoside and Nucleotide Analogue Drug Exposure
  Antiviral Therapy, 2001
• Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia
  New England Journal of Medicine, 2001
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
  The Lancet, 1999
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care
  Medical Care, 1994
• Significance testing in the comparison of survival curves from clinical trials of cancer treatment
  European Journal of Cancer and Clinical Oncology, 1986